P

Assignee

INTERNEURON PHARMA

US15 patents

Top patents by PatentIndex Score

US5019594AMay 28, 1991

Method for decreasing appetite

INTERNEURON PHARMA58 citations94
US5580878ADec 3, 1996

Substituted tryptamines phenalkylamines and related compounds

INTERNEURON PHARMA66 citations93
US5403851AApr 4, 1995

Substituted tryptamines, phenalkylamines and related compounds

INTERNEURON PHARMA93 citations93
US5096712AMar 17, 1992

Method for enhancing performance so as to improve vigor and decrease fatigue, confusion, tension, and anxiety

INTERNEURON PHARMA25 citations93
US5260091ANov 9, 1993

Salt taste enhancers

INTERNEURON PHARMA21 citations90
US5872108AFeb 16, 1999

Reduction of infarct volume using citicoline

INTERNEURON PHARMA22 citations89
US5827832AOct 27, 1998

Method of protecting brain tissue from cerebral infarction subsequent to ischemia

INTERNEURON PHARMA29 citations89
US5744476AApr 28, 1998

Dopamine D1 agonists for the treatment of dementia

INTERNEURON PHARMA45 citations86
US5206218AApr 27, 1993

Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa)

INTERNEURON PHARMA8 citations73
US5206049AApr 27, 1993

Choline-containing compositions as salt substitutes and enhancers and a method of preparation

INTERNEURON PHARMA18 citations72
US5801160ASep 1, 1998

Method of protecting brain tissue from cerebral infarction subsequent to ischemia

INTERNEURON PHARMA12 citations67
US5698525ADec 16, 1997

Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)

INTERNEURON PHARMA2 citations62
US5432162AJul 11, 1995

Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (LNAA)

INTERNEURON PHARMA0 citations52
US6451523B1Sep 17, 2002

Detection of a leptin receptor variant and methods for regulating obesity

INTERNEURON PHARMA0 citations51
US6057301AMay 2, 2000

Hyperhydrated citicoline, process and use

INTERNEURON PHARMA4 citations46